You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
君實生物AH股齊步走強
格隆匯5月12日丨君實生物AH股盤中齊步走強,A股一度漲15%報131.42元,H股一度漲超8%至68.65港元。消息面上,公司稱上海臨港生產基地作為臨港新片區內重點生物醫藥產業化基地,在被列入第一批覆工復產白名單後已迅速啟動復工安排,目前已完成藥品生產環境恢復,並啟動多款商業化和臨牀階段產品的大規模生產,將為患者用藥的持續供應保駕護航。另外,公司日前宣佈收到國家藥品監督管理局核准簽發的藥品補充申請批准通知書,批准公司全資附屬公司上海君實生物工程有限公司位於上海臨港的生產基地可與公司蘇州吳江生產基地同時負責生產商業化批次的特瑞普利單抗注射液(商品名:拓益,產品代號:JS001)。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account